These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Gentamicin and tobramycin pharmacokinetics in patients with cystic fibrosis. Bauer LA; Piecoro JJ; Wilson HD; Blouin RA Clin Pharm; 1983; 2(3):262-4. PubMed ID: 6883955 [TBL] [Abstract][Full Text] [Related]
3. [Acute pneumonia treatment with a new antibiotic (tobramycin) (author's transl)]. de Campos EP; Meira DA; Mendes RP; de Campos CE Rev Bras Pesqui Med Biol; 1978 Dec; 11(6):369-76. PubMed ID: 751115 [TBL] [Abstract][Full Text] [Related]
4. Bacterial incidence and antibiotic sensitivity pattern in moderate and severe infections in hospitalised patients. Ghosh A; Karmakar PS; Pal J; Chakraborty N; Debnath NB; Mukherjee JD J Indian Med Assoc; 2009 Jan; 107(1):21-2, 24-5. PubMed ID: 19588683 [TBL] [Abstract][Full Text] [Related]
6. High-dose tobramycin combined with clindamycin or lincomycin in the treatment of septic peritonitis and intraabdominal sepsis. Muth L; Edén T Acta Chir Scand; 1981; 147(5):339-46. PubMed ID: 7324760 [TBL] [Abstract][Full Text] [Related]
7. Inhaled tobramycin in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection with Pseudomonas aeruginosa. Drobnic ME; Suñé P; Montoro JB; Ferrer A; Orriols R Ann Pharmacother; 2005 Jan; 39(1):39-44. PubMed ID: 15562142 [TBL] [Abstract][Full Text] [Related]
8. Comparison of empiric aztreonam and aminoglycoside regimens in the treatment of serious gram-negative lower respiratory infections. Bjornson HS; Ramirez-Ronda C; Saavedra S; Rivera-Vázquez CR; Liu C; Hinthorn DR Clin Ther; 1993; 15(1):65-78. PubMed ID: 8458056 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic variability of extended interval tobramycin in burn patients. Bracco D; Landry C; Dubois MJ; Eggimann P Burns; 2008 Sep; 34(6):791-6. PubMed ID: 18395988 [TBL] [Abstract][Full Text] [Related]
11. Control of bacterial pneumonia during mechanical ventilation. Kolak J; van Saene HK; de la Cal MA; Silvestre L; Peric M Croat Med J; 2005 Apr; 46(2):183-96. PubMed ID: 15849838 [TBL] [Abstract][Full Text] [Related]
12. Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis. Michalopoulos A; Kasiakou SK; Mastora Z; Rellos K; Kapaskelis AM; Falagas ME Crit Care; 2005 Feb; 9(1):R53-9. PubMed ID: 15693967 [TBL] [Abstract][Full Text] [Related]
13. Tobramycin for nebulisation: new formulation. A high price for a small improvement in formulation. Prescrire Int; 2002 Dec; 11(62):177-8. PubMed ID: 12469696 [TBL] [Abstract][Full Text] [Related]
14. [Individualized monitoring of the therapy with gentamycin using pharmacokinetic methods. Which method to choose?]. Carvalho A; Fonseca C; Falcão F; Pereira TA; Freitas O; Parrinha A; Costa M; Rodrigues MJ; Ceia F; Luís AS Acta Med Port; 1996; 9(7-9):187-95. PubMed ID: 9005695 [TBL] [Abstract][Full Text] [Related]
15. Effect of pharmacokinetic sampling methods on aminoglycoside dosing in critically ill surgery patients. Mann HJ; Wittbrodt ET; Baghaie AA; Cerra FB Pharmacotherapy; 1998; 18(2):371-8. PubMed ID: 9545157 [TBL] [Abstract][Full Text] [Related]
19. [Comparison of the pharmacokinetics of tobramycin administered in a single daily dose or in 3 doses in cystic fibrosis]. Canis F; Trivier D; Vic P; Ategbo S; Turck D; Husson MO Pathol Biol (Paris); 1998 Jun; 46(6):449-51. PubMed ID: 9769880 [TBL] [Abstract][Full Text] [Related]
20. Aminoglycosides in intermittent hemodialysis: pharmacokinetics with individual dosing. Dager WE; King JH Ann Pharmacother; 2006 Jan; 40(1):9-14. PubMed ID: 16332944 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]